BSEInsider Trading / SAST30 Sept 2026 · 30 Sept 2026, 11:39 am

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund

Gland Pharma Ltd · 543245

✦ AI SummaryRelated Party

Gland Pharma Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Mirae Asset Mutual Fund, indicating a potential change in shareholding.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gland Pharma Ltd - 543245 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

03556953_DD8B_467E_ABB4_4B4FE42B4B49_113904.pdf

pdf

Download →